Adrenal crisis

Last updated
Adrenal crisis
Other namesAcute adrenal insufficiency, Addisonian crisis, Acute adrenal failure. [1]
AdrenalCrisis.jpg
49-year-old with an adrenal crisis. Appearance, showing lack of facial hair, dehydration, Queen Anne's sign (panel A), pale skin, muscular and weight loss, and loss of body hair (panel B).
Pronunciation
  • /əˈdriː.nəl/ [2] /ˈkraɪ.sɪs/ [3]
Specialty Emergency medicine, Endocrinology
Symptoms Dizziness, somnolence, confusion, loss of consciousness, nausea, vomiting, abdominal pain, decreased appetite, extreme exhaustion, unintended weight loss, weakness, and hypotension. [4]
Complications Seizures, arrhythmias, organ damage, coma, and death. [4]
Causes Adrenal insufficiency, thyrotoxicosis, infections, trauma, pregnancy, and surgery. [4]
Risk factors Adrenal insufficiency, polyglandular autoimmune syndromes, glucocorticoids, levothyroxine, and rifampin. [4]
Diagnostic method ACTH, basic metabolic panel, and cortisol. [4]
Differential diagnosis Myocardial infarction, trauma, stress, myxedema coma, circulatory shock, septic shock, and infection. [4]
PreventionProviding intramuscular hydrocortisone at home and using sick day rules. [4]
TreatmentSteroid replacement and fluid resuscitation. [5]
Medication Hydrocortisone. [4]
Prognosis 6% mortality rate. [6]
Frequency6–8% of those with adrenal insufficiency annually. [7]

Adrenal crisis, also known as Addisonian crisis or acute adrenal insufficiency, is a serious, life-threatening complication of adrenal insufficiency. Hypotension, or hypovolemic shock, is the main symptom of adrenal crisis. Other symptoms include weakness, anorexia, nausea, vomiting, fever, fatigue, abnormal electrolytes, confusion, and coma. [8] Laboratory testing may detect lymphocytosis, eosinophilia, hyponatremia, hyperkalemia, hypoglycemia, and occasionally, hypercalcemia. [9]

Contents

The biggest trigger for adrenal crisis is gastrointestinal illness. [10] The physiological mechanisms underlying an adrenal crisis involve the loss of endogenous glucocorticoids' typical inhibitory effect on inflammatory cytokines. [9]

When a patient with adrenal insufficiency exhibits symptoms of an adrenal crisis, treatment should begin immediately. [11] To diagnose an adrenal crisis, serum cortisol, aldosterone, ACTH, renin, and dehydroepiandrosterone-sulfate should be measured. [8] A low cortisol level of less than 5 mg/dL (138 nmol/L), measured in the early morning or during a stressful period, suggests a diagnosis of adrenal insufficiency. [12]

A tailored prescription, as well as a strategy for administering additional glucocorticoids for physiological stress, are critical preventative measures. When an adult experiences an adrenal crisis, they require immediate parenteral hydrocortisone. [13]

About 6 to 8% of patients with adrenal insufficiency experience an adrenal crisis at some point each year. [7] The mortality rate linked to adrenal crises is up to 6%. [6]

Signs and symptoms

In as many as 50% of Addison's disease patients, adrenal crisis can be the first symptom of adrenal insufficiency. [14] Diagnosis is often delayed since most of the signs and symptoms of adrenal insufficiency are nonspecific and develop insidiously. Symptoms include orthostatic hypotension, lethargy, fever, nausea, fatigue, anorexia, abdominal pain, weakness, hyperpigmentation, joint pain, and weight loss. Those in an adrenal crisis often go into hypotensive shock and may exhibit sensorium alterations. They often present with gastrointestinal symptoms such as nausea, vomiting, diarrhea, and abdominal pain, which can mistakenly be diagnosed as gastroenteritis or an acute abdomen. [5]

Glucocorticoids have a permissive effect on catecholamine action, which leads to hypotension secondary to hypovolemia and hypocortisolism in their absence. [15] Hypovolemia might be resistant to inotropes and fluids if it is not identified. In secondary adrenal insufficiency, hyponatremia results from decreased kidney excretion of electrolyte-free water and the inability to suppress vasopressin. [5]

Hyponatremia in primary adrenal insufficiency is caused by concurrent aldosterone deficiency, resulting in volume depletion, natriuresis, and hyperkalemia. [16] Additional biochemical characteristics include hypercalcemia, which is a result of increased bone resorption and reduced renal excretion of calcium, and hypoglycemia, which occurs rarely. [17]

Causes

An absolute or relative lack of cortisol, causes adrenal crises as there is not enough tissue glucocorticoid activity to preserve homeostasis. [9]

An adrenal crisis can be caused by adrenal insufficiency. Adrenal insufficiency can be classified into primary adrenal insufficiency caused by conditions affecting the adrenal cortex, secondary adrenal insufficiency due to ACTH deficiency caused by conditions affecting the hypothalamus or pituitary gland, or tertiary adrenal insufficiency caused by excessive glucocorticoid exposure. Adrenal insufficiency can be caused by autoimmune disorders such as autoimmune adrenalitis, autoimmune polyglandular syndrome, and lymphocytic hypophysitis, congenital disorders such as congenital adrenal hyperplasia, adrenoleukodystrophy, familial glucocorticoid deficiency, combined pituitary hormone deficiency, and POMC mutation. Adrenal insufficiency can also be caused by pituitary or adrenal gland surgeries. Infections such as tuberculosis, histoplasmosis, HIV, and CMV can also cause adrenal insufficiency. Infiltrative disorders like sarcoidosis, amyloidosis, and haemochromatosis have been known to cause adrenal insufficiency. Hemorrhages in the pituitary and adrenal glands, Waterhouse-Friderichsen syndrome, vasculitis, pituitary apoplexy, and Sheehan’s syndrome are vascular disorders that can cause adrenal insufficiency. Tumors on the pituitary gland or cancer metastasis can also cause adrenal insufficiency. [18]

Exogenous steroid use is the most frequent cause of adrenal insufficiency, [11] and patients who use these drugs also run the risk of experiencing an adrenal crisis. Adrenal crisis can result from abrupt, and frequently unintentional, steroid withdrawal. [5] The hypothalamus-pituitary-adrenal axis has been reported to be suppressed by the use of glucocorticoids in rectal, [19] paraspinal, [20] intradermal, [21] intraarticular, [22] injectable, [23] nasal, [24] inhaled, [25] or topical preparations. [26] At pharmacological dosages, medroxyprogesterone and megestrol also exhibit a notable glucocorticoid effect. [27] This risk may increase if steroids are used concurrently with ritonavir or, which inhibit the liver's CYP3A enzyme that breaks down steroids. [28] [29]

There is a greater risk for adrenal suppression with longer durations, greater doses, and oral and intraarticular preparations. Nonetheless, no amount, time frame, or mode of administration can reliably predict adrenal insufficiency. [30]

Risk factors

Because of the lack of mineralocorticoids and increased risk of dehydration and hypovolemia, those with primary adrenal insufficiency might be more susceptible to adrenal crisis compared to individuals with secondary adrenal insufficiency. [6]

Individuals with secondary adrenal insufficiency who have diabetes insipidus are more likely to experience an adrenal crisis. This increased risk could be attributed to either the absence of V1-receptor-mediated vasoconstriction throughout extreme stress or the increased risk of dehydration. [31] A higher risk of adrenal crisis has been linked in some studies to other medical conditions like hypogonadism [10] and type 1 and type 2 diabetes, though the exact mechanism is unknown. [32]

Patients with adrenal insufficiency have a 50% lifetime risk of experiencing an adrenal crisis, [5] and those who have experienced an adrenal crisis in the past seem to be more susceptible to another episode. [6]

Triggers

A known precipitating event can be found in over 90% of episodes of adrenal crisis. [5] The most common cause of adrenal crisis is gastrointestinal illness. This is probably because it has a direct impact on how well oral glucocorticoids are absorbed through the intestines. [6] Stress from surgery is another common cause. [32]

Those who have autoimmune polyendocrine syndrome type 2 might have concurrent thyroid and adrenal insufficiency. Levothyroxine can speed up the peripheral metabolism of cortisol and trigger an adrenal crisis in individuals with undetected adrenal insufficiency as well as those already on replacement steroids. [33] Cytochrome P-450 enzyme inducers, such as phenobarbitone, rifampicin, and phenytoin, may trigger an adrenal crisis. [34] Therefore, glucocorticoid dosages should be appropriately increased in those with tuberculosis-associated adrenal insufficiency starting rifampicin. [35]

An adrenal crisis can also be brought on by emotional stress in addition to physical stress. [6]

Mechanism

An absolute or relative lack of cortisol, an endogenous glucocorticoid, causes adrenal crises because there is not enough tissue glucocorticoid activity to preserve homeostasis. [9]

Left: DNA-binding domains of a glucocorticoid receptor homodimer in the nucleus interacting with DNA. Right: Binding of synthetic glucocorticoid dexamethasone to ligand-binding domain of receptor in cytoplasm. Glucocorticoid receptor.png
Left: DNA-binding domains of a glucocorticoid receptor homodimer in the nucleus interacting with DNA. Right: Binding of synthetic glucocorticoid dexamethasone to ligand-binding domain of receptor in cytoplasm.


Cortisol has a 70 to 120 minute half-life meaning that cortisol levels within several hours of cortisol deprivation. [36] Because cortisol modulates the transcription of genes containing a glucocorticoid response element, it has extremely pleiotropic effects. The physiological effects of low cortisol begin with the loss of the natural inhibitory function of endogenous glucocorticoids on inflammatory cytokines. This leads to sharp rises in cytokine concentrations, which induce fever, lethargy, anorexia, and pain in the body. As a result, insufficient cortisol causes immune-cell populations to change, including lymphocytosis, eosinophilia, and neutropenia; [9] it also loses its ability to work in concert with catecholamines to reduce vascular reactivity, which causes vasodilatation and hypotension; [37] it has an adverse effect on the liver's intermediary metabolism, resulting in hypoglycemia, decreased gluconeogenesis, or both; and it lower levels of free fatty acids and amino acids in circulation. [38]

Loss of cortisol suppresses nuclear factor κB (NF-κB) and activator protein 1 (AP-1) at the cellular level, which allows genes that generate inflammatory proteins to be activated without restriction. This is because cortisol normally inhibits NF-κB's binding to the glucocorticoid receptor. [9] Additionally, through potassium retention and sodium and water loss, mineralocorticoid deficiency—which is common in primary but not in secondary adrenal insufficiency—is likely to aggravate adrenal crises. [31]

Diagnosis

When a patient with adrenal insufficiency is known to be exhibiting symptoms of an adrenal crisis, treatment needs to start right away. When a patient is deemed medically unstable, treatment shouldn't be postponed in even when diagnosis is still pending. [11]

Change in plasma cortisol cycle (mcg/dl) over 24 hours Change in plasma cortisol cycle over 24 hours.jpg
Change in plasma cortisol cycle (mcg/dl) over 24 hours

Adrenal insufficiency can be diagnosed with renin, dehydroepiandrosterone sulfate, aldosterone, serum cortisol, and ACTH levels which can be taken right before hydrocortisone is administered. A high cortisol level of more than 20 mg/dL (550 nmol/L) can rule out the diagnosis. [8] A low cortisol level of less than 5 mg/dL (138 nmol/L), obtained in the early morning or during a stressful period, strongly suggests the possibility of adrenal insufficiency. [12] In instances of primary adrenal insufficiency, there is a correspondingly high ACTH level; in contrast, low or inappropriately normal ACTH correlates with tertiary or secondary adrenal insufficiency. [17]

When in doubt, the patient should receive glucocorticoid therapy until they have fully recovered, at which point a safe diagnostic test, like an ACTH stimulation test, can be performed. The hypothalamic-pituitary-adrenal axis can be affected by prolonged glucocorticoid treatment, so this test should be done as soon as possible. [5]

Prevention

A customized prescription as well as a plan for the administration of additional glucocorticoids for physiological stress are important preventative measures. If oral glucocorticoids are not an option, parenteral hydrocortisone should be used, preferably at home. Devices like MedicAlert bracelets and necklaces can alert caregivers to the possibility of adrenal crisis in patients who are unable to communicate verbally. [9]

Hydrocortisone 100mg vial Hydrocortisone 100mg vial white background.jpg
Hydrocortisone 100mg vial

Although the exact dosage has been debated, it is generally agreed upon that all patients with proven adrenal insufficiency should receive glucocorticoid replacement during stressful times. The recommended amounts of glucocorticoid replacement are dependent on the anticipated stress, and the current guidelines depend on expert opinion. [39] Though there may be variations in specific regimens, most agree that stress doses for simple surgery should be quickly tapered and should not last longer than three days. This is because unneeded steroid excess can lead to infections, poor wound healing, and hyperglycemia. [5]

In those who are unable to tolerate oral medication or do not respond to stress doses, a low threshold to initiate parenteral hydrocortisone management should be used to guarantee adequate systemic absorption, since gastroenteritis frequently precedes an adrenal crisis [6] and a rise in oral glucocorticoids may not always avoid an adrenal crisis. [40]

Patients experiencing vomiting, chronic diarrhea, or an imminent adrenal crisis should receive intramuscular hydrocortisone. Patients must be prepared to administer it themselves because they can rapidly deteriorate. [39] A lot of patients may own a hydrocortisone ampoule, [41] but not all have practiced the injection, and most will depend on medical professionals to give it to them in the event of an adrenal crisis episode. [32] Patients may experience significant physical as well as cognitive impairment during their illness, which may impair their capacity to make wise decisions or administer medicine. [42] Therefore, patients should receive training on intramuscular hydrocortisone use and education on how to recognize an adrenal crisis, as well as assistance from a close family member or friend. [39]

In case an individual suffering from adrenal insufficiency loses consciousness, they must receive the necessary medical attention. Reminding patients to always wear or keep a MedicAlert bracelet or just an emergency card is important. [43] A survey of 46 patients revealed that some medical professionals are reluctant to medicate the condition even when it is brought to their attention, which is a serious cause for concern. Only 54% of patients got glucocorticoid administration within 30 minutes of arrival, even though 86% of patients were promptly attended to by a medical professional within forty-five minutes of a distress call. [44] In situations when doctors are unsure about a patient's need for additional hydrocortisone, it is wise to listen to patients and their loved ones as they frequently have the most knowledge about this rare disorder. [45]

Treatment

The two foundations of treatment for adrenal crisis are steroid replacement and fluid resuscitation. [5] When adrenal crisis treatment is started as soon as possible, it can be effective in preventing irreversible effects from prolonged hypotension. [9] Treatment shouldn't be postponed while doing diagnostic tests. If there is reason to suspect something, a blood sample could be taken right away for ACTH and serum cortisol testing; however, treatment needs to begin right away, regardless of the results of the assay. Once a patient has recovered clinically, it is safe to confirm the diagnosis in an acutely ill patient. [46]

In cases of emergency, parenteral hydrocortisone can be given as soon as possible by intramuscular (IM) injection while IV access is being established, or as a bolus injection of 100 mg of intravenous (IV) hydrocortisone. After this bolus, 200 mg of hydrocortisone should be administered every 24 hours, either continuously by IV infusion or, if that is not possible, in doses of 50 mg of hydrocortisone per IV/IM injection every 6 hours. [47] A constant infusion of hydrocortisone results in a cortisol concentration insert at a steady state. [48]

Hypovolemia and hyponatremia can be corrected with intravenous fluid resuscitation using isotonic sodium chloride 0.9%; the hypoglycemia may also need to be corrected with intravenous dextrose. Over the course of the first hour, a liter of saline 0.9% must be administered. Subsequent replacement fluids should be determined by measuring the serum electrolytes and conducting frequent hemodynamic monitoring. [49] In cases of secondary adrenal insufficiency, cortisol replacement can cause water diuresis along with suppress antidiuretic hormone. When combined with sodium replacement, these effects can quickly correct hyponatremia as well as osmotic demyelination syndrome. As a result, care must be taken to adjust sodium by less than 10 mEq during the first 24 hours. [50]

It is widely acknowledged that extra mineralocorticoid treatment is not necessary at hydrocortisone dosages greater than 50 mg/day because there is adequate action within the mineralocorticoid receptor. [8] In those who have primary adrenal insufficiency, fludrocortisone needs to be started with subsequent dose tapering; for most patients, a daily dose of 50–200 mcg is adequate. [49] According to current treatment guidelines of primary adrenal insufficiency, the doses of prednisolone and dexamethasone are recommended based on their glucocorticoid potency in relation to hydrocortisone. [47]

Patients with lymphocytic hypophysitis can experience both adrenal insufficiency as well as diabetes insipidus. Whether or not a patient is receiving treatment for diabetes insipidus, fluid administration should be done carefully because too much fluid can lead to hypernatremia and too little water can cause hyponatremia. Hyponatremia is typically maintained with careful synchronization of urine output and a normal saline infusion. [7]

Outlook

Patients with hypoadrenalism are more likely to die from adrenal crises; the death rate from adrenal crises can amount to 6% of crisis events. [6] "Adrenal failure" accounted for 15% of deaths in a study conducted in Norway involving 130 Addison's disease patients, making it the second most common cause of death. [51] While symptoms may have gone unnoticed prior to the fatal episode, fatal adrenal crises have happened in patients who had never been diagnosed with hypoadrenalism. [52]

Epidemiology

An adrenal crisis occurs in roughly 6–8% of those with adrenal insufficiency annually. [7] Patients with primary hypoadrenalism experience adrenal crises somewhat more frequently compared to those with secondary adrenal insufficiency. [31] This is likely due to the fact that patients with primary hypoadrenalism lack mineralocorticoid secretion and some secondary adrenal insufficiency patients retain some cortisol secretion. [53] Despite varying degrees of consequent adrenal suppression, patients with hypoadrenalism from long-term glucocorticoid therapy rarely experience adrenal crises. [54]

Special populations

Geriatrics

T1-weighted post contrast coronal section of non-functioning pituitary adenoma. The tumor is seen extending into the right cavernous sinus. Coronal section of non-functioning pituitary adenoma.jpg
T1-weighted post contrast coronal section of non-functioning pituitary adenoma. The tumor is seen extending into the right cavernous sinus.

All age groups are susceptible to misclassification of an adrenal crisis diagnosis, [7] but older patients may be more vulnerable if relative hypotension is not evaluated, given the age-related rise in blood pressure. [55] It is possible to confuse hyponatremia—a common sign of adrenal insufficiency or adrenal crisis—with the syndrome of inappropriate antidiuretic hormone secretion, which is frequently brought on by disease, drugs, or aging itself. [56]

The treatment of pituitary tumors and the widespread use of opioids for both malignant and increasingly non-malignant pain, as well as exogenous glucocorticoid therapy for the numerous inflammatory as well as malignant conditions that become more common in people over 60, are the main causes of a new diagnosis of adrenal insufficiency in older adults. [57] [54] Adrenal crisis is more likely to occur in older people. [58] Urinary tract infections, particularly in older women, are often linked to an adrenal crisis, as is pneumonia as well as a flare-up of chronic respiratory disease. [59] Cellulitis is linked to adrenal crises within this age range and may be more prevalent in patients with fragile skin who have been exposed to higher doses of glucocorticoids. [60] Older adults frequently experience falls and fractures, which may be linked to postural hypotension, especially in those who have primary adrenal insufficiency. [61]

Older patients have a higher mortality rate from adrenal crisis, at least in part due to the existence of comorbidities that make treatment more difficult. [62]

While studies on the prevalence of adrenal crisis in older adults are scarce, one population-based investigation into hospital admissions for adrenal crisis found that the incidence increased with age in older patients, going from 24·3 (60–69 years) to 35·2 (70–79 years) and 45·8 (80+ years) per million per year. This is significantly higher compared to the general adult admission rate, which is 15·0 per million annually in the same population. [60]

Pregnancy

Most cases of adrenal insufficiency in pregnancy are identified before conception. Because the symptoms of hyperemesis gravidarum (fatigue, vomiting, nausea, and mild hypotension) and normal pregnancy (nausea and vomiting) overlap, there is usually little clinical indication of adrenal insufficiency during pregnancy. [63] Adrenal insufficiency during pregnancy has only been documented in 100 cases as of 2018. [64]

Untreated adrenal crisis can cause severe morbidity in both the mother and the fetus, such as inadequate wound healing, infection, venous thromboembolism, extended hospital stays, preterm birth, fetal intrauterine growth restriction, and an increased risk of cesarean delivery. [65] The occurrence of adrenal crisis during pregnancy is uncommon, even in patients who have a documented history of adrenal insufficiency. In one study, pregnancy was identified as a trigger for adrenal crisis in 0.2% of the 423 patients. In a different study only 1.1% of the 93 patients in the study who had a known insufficiency experienced an adrenal crisis during pregnancy. [66]

Children

Fluorodeoxyglucose Positron emission tomography-CT scan shows enlarged adrenals with masses. Genetic and biochemical workup was consistent with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. CT scan shows enlarged adrenals with masses consistent with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.png
Fluorodeoxyglucose Positron emission tomography–CT scan shows enlarged adrenals with masses. Genetic and biochemical workup was consistent with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

A common finding in children experiencing an adrenal crisis is hypoglycemia. This could be linked to seizures, which are extremely dangerous and can result in permanent brain damage or even death. [67] Due to issues with adrenomedullary development as well as epinephrine production, hypoglycemia, and hemodynamic disturbance may be more prominent in the context of acute adrenal insufficiency in congenital conditions, including congenital adrenal hyperplasia, compared to other forms of primary adrenal insufficiency. [68] The severity of the enzyme impairment is correlated with the degree of adrenomedullary dysfunction. [69] Severe hyperkalemia has also been linked to potentially fatal cardiac arrhythmias. [70] Because the renal tubules' function is still developing in infants and early children with primary adrenal insufficiency, hyponatremia is of particular concern. [68]

Studies have demonstrated that younger children with congenital adrenal hyperplasia experience adrenal crisis events more frequently than older children and adolescents. [71] Furthermore, research on congenital adrenal hyperplasia in children shows that individuals with more severe salt-wasting types have a higher chance of needing to be hospitalized. [72] There are differences in the incidence of adrenal crises between the sexes, and these differences change with age. [73] Psychosocial factors have the potential to alter the baseline adrenal crisis risk as well, especially as patients transition from parental treatment oversight to self-management in adolescence. [74] Management in this age group is further complicated by changes in cortisol pharmacokinetics, resulting in an increased clearance as well as volume without a change to the cortisol half-life that has been shown during the pubertal period. [75]

There is still a significant morbidity and death associated with adrenal insufficiency in newborns and early children. It has been estimated that 5–10 episodes of adrenal crisis occur for every 100 patient years in children with adrenal insufficiency; incidences may be higher in specific countries. Adrenal crisis among kids results in death in about 1/200 cases. [13]

See also

Related Research Articles

<span class="mw-page-title-main">Adrenal gland</span> Endocrine gland

The adrenal glands are endocrine glands that produce a variety of hormones including adrenaline and the steroids aldosterone and cortisol. They are found above the kidneys. Each gland has an outer cortex which produces steroid hormones and an inner medulla. The adrenal cortex itself is divided into three main zones: the zona glomerulosa, the zona fasciculata and the zona reticularis.

<span class="mw-page-title-main">Cushing's syndrome</span> Symptoms from excessive exposure to glucocorticoids such as cortisol

Cushing's syndrome is a collection of signs and symptoms due to prolonged exposure to glucocorticoids such as cortisol. Signs and symptoms may include high blood pressure, abdominal obesity but with thin arms and legs, reddish stretch marks, a round red face due to facial plethora, a fat lump between the shoulders, weak muscles, weak bones, acne, and fragile skin that heals poorly. Women may have more hair and irregular menstruation. Occasionally there may be changes in mood, headaches, and a chronic feeling of tiredness.

<span class="mw-page-title-main">Cortisol</span> Human natural glucocorticoid hormone

Cortisol is a steroid hormone, in the glucocorticoid class of hormones and a stress hormone. When used as a medication, it is known as hydrocortisone.

<span class="mw-page-title-main">Addison's disease</span> Endocrine disorder

Addison's disease, also known as primary adrenal insufficiency, is a rare long-term endocrine disorder characterized by inadequate production of the steroid hormones cortisol and aldosterone by the two outer layers of the cells of the adrenal glands, causing adrenal insufficiency. Symptoms generally come on slowly and insidiously and may include abdominal pain and gastrointestinal abnormalities, weakness, and weight loss. Darkening of the skin in certain areas may also occur. Under certain circumstances, an adrenal crisis may occur with low blood pressure, vomiting, lower back pain, and loss of consciousness. Mood changes may also occur. Rapid onset of symptoms indicates acute adrenal failure, which is a clinical emergency. An adrenal crisis can be triggered by stress, such as from an injury, surgery, or infection.

<span class="mw-page-title-main">Congenital adrenal hyperplasia</span> Medical condition

Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders characterized by impaired cortisol synthesis. It results from the deficiency of one of the five enzymes required for the synthesis of cortisol in the adrenal cortex. Most of these disorders involve excessive or deficient production of hormones such as glucocorticoids, mineralocorticoids, or sex steroids, and can alter development of primary or secondary sex characteristics in some affected infants, children, or adults. It is one of the most common autosomal recessive disorders in humans.

<span class="mw-page-title-main">Hydrocortisone</span> Glucocorticoid and Mineralocorticoid hormone Cortisol supplied as a medication

Hydrocortisone is the name for the hormone cortisol when supplied as a medication. Uses include conditions such as adrenocortical insufficiency, adrenogenital syndrome, high blood calcium, thyroiditis, rheumatoid arthritis, dermatitis, asthma, and COPD. It is the treatment of choice for adrenocortical insufficiency. It can be given by mouth, topically, or by injection. Stopping treatment after long-term use should be done slowly.

<span class="mw-page-title-main">Adrenal insufficiency</span> Medical condition

Adrenal insufficiency is a condition in which the adrenal glands do not produce adequate amounts of steroid hormones. The adrenal glands—also referred to as the adrenal cortex—normally secrete glucocorticoids, mineralocorticoids, and androgens. These hormones are important in regulating blood pressure, electrolytes, and metabolism as a whole. Deficiency of these hormones leads to symptoms ranging from abdominal pain, vomiting, muscle weakness and fatigue, low blood pressure, depression, mood and personality changes to organ failure and shock. Adrenal crisis may occur if a person having adrenal insufficiency experiences stresses, such as an accident, injury, surgery, or severe infection; this is a life-threatening medical condition resulting from severe deficiency of cortisol in the body. Death may quickly follow.

Corticotropes are basophilic cells in the anterior pituitary that produce pro-opiomelanocortin (POMC) which undergoes cleavage to adrenocorticotropin (ACTH), β-lipotropin (β-LPH), and melanocyte-stimulating hormone (MSH). These cells are stimulated by corticotropin releasing hormone (CRH) and make up 15–20% of the cells in the anterior pituitary. The release of ACTH from the corticotropic cells is controlled by CRH, which is formed in the cell bodies of parvocellular neurosecretory cells within the paraventricular nucleus of the hypothalamus and passes to the corticotropes in the anterior pituitary via the hypophyseal portal system. Adrenocorticotropin hormone stimulates the adrenal cortex to release glucocorticoids and plays an important role in the stress response.

<span class="mw-page-title-main">Congenital adrenal hyperplasia due to 21-hydroxylase deficiency</span> Medical condition

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH) is a genetic disorder characterized by impaired production of cortisol in the adrenal glands.

<span class="mw-page-title-main">Adrenalectomy</span> Surgical removal of adrenal glands

Adrenalectomy is the surgical removal of one or both adrenal glands. It is usually done to remove tumors of the adrenal glands that are producing excess hormones or is large in size. Adrenalectomy can also be done to remove a cancerous tumor of the adrenal glands, or cancer that has spread from another location, such as the kidney or lung. Adrenalectomy is not performed on those who have severe coagulopathy or whose heart and lungs are too weak to undergo surgery. The procedure can be performed using an open incision (laparotomy) or minimally invasive laparoscopic or robot-assisted techniques. Minimally invasive techniques are increasingly the gold standard of care due to shorter length of stay in the hospital, lower blood loss, and similar complication rates.

<span class="mw-page-title-main">Adrenocorticotropic hormone deficiency</span> Medical condition

Adrenocorticotropic hormone deficiency is a rare disorder characterized by secondary adrenal insufficiency with minimal or no cortisol production and normal pituitary hormone secretion apart from ACTH. ACTH deficiency may be congenital or acquired, and its symptoms are clinically similar to those of glucocorticoid deficiency. Symptoms consist of weight loss, diminished appetite, muscle weakness, nausea, vomiting, and hypotension. Low blood sugar and hyponatremia are possible; however, blood potassium levels typically remain normal because affected patients are deficient in glucocorticoids rather than mineralocorticoids because of their intact renin-angiotensin-aldosterone system. ACTH may be undetectable in blood tests, and cortisol is abnormally low. Glucocorticoid replacement therapy is required. With the exception of stressful situations, some patients with mild or nearly asymptomatic disease may not require glucocorticoid replacement therapy. As of 2008 about two hundred cases have been described in the literature.

Stress hormones are secreted by endocrine glands to modify one's internal environment during the times of stress. By performing various functions such as mobilizing energy sources, increasing heart rate, and downregulating metabolic processes which are not immediately necessary, stress hormones promote the survival of the organism. The secretions of some hormones are also downplayed during stress. Stress hormones include, but are not limited to:

<span class="mw-page-title-main">11-Deoxycortisol</span> Chemical compound

11-Deoxycortisol, also known as cortodoxone (INN), cortexolone as well as 17α,21-dihydroxyprogesterone or 17α,21-dihydroxypregn-4-ene-3,20-dione, is an endogenous glucocorticoid steroid hormone, and a metabolic intermediate toward cortisol. It was first described by Tadeusz Reichstein in 1938 as Substance S, thus has also been referred to as Reichstein's Substance S or Compound S.

The ACTH test is a medical test usually requested and interpreted by endocrinologists to assess the functioning of the adrenal glands' stress response by measuring the adrenal response to adrenocorticotropic hormone or another corticotropic agent such as tetracosactide or alsactide (Synchrodyn). ACTH is a hormone produced in the anterior pituitary gland that stimulates the adrenal glands to release cortisol, dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEA-S), and aldosterone.

Critical illness–related corticosteroid insufficiency is a form of adrenal insufficiency in critically ill patients who have blood corticosteroid levels which are inadequate for the severe stress response they experience. Combined with decreased glucocorticoid receptor sensitivity and tissue response to corticosteroids, this adrenal insufficiency constitutes a negative prognostic factor for intensive care patients.

Hypoadrenocorticism in dogs, or, as it is known in people, Addison's disease, is an endocrine system disorder that occurs when the adrenal glands fail to produce enough hormones for normal function. The adrenal glands secrete glucocorticoids such as cortisol and mineralocorticoids such as aldosterone; when proper amounts of these are not produced, the metabolic and electrolyte balance is upset. Mineralocorticoids control the amount of potassium, sodium, and water in the body. Hypoadrenocorticism is fatal if left untreated.

<span class="mw-page-title-main">Adrenal gland disorder</span> Medical condition

Adrenal gland disorders are conditions that interfere with the normal functioning of the adrenal glands. Your body produces too much or too little of one or more hormones when you have an adrenal gland dysfunction. The type of issue you have and the degree to which it affects your body's hormone levels determine the symptoms.

Glucocorticoid deficiency is a condition where the body doesn’t produce enough glucocorticoid hormones.

Late onset congenital adrenal hyperplasia (LOCAH), also known as nonclassic congenital adrenal hyperplasia, is a milder form of congenital adrenal hyperplasia (CAH), a group of autosomal recessive disorders characterized by impaired cortisol synthesis that leads to variable degrees of postnatal androgen excess.

<span class="mw-page-title-main">Generalized glucocorticoid resistance</span> Medical condition

Generalized glucocorticoid resistance or Chrousos syndrome is a rare genetic disorder that can run in families or be sporadic. It is characterized by partial or generalized target-tissue insensitivity to glucocorticoids.

References

  1. ↑ "Monarch Initiative". Monarch Initiative. Retrieved December 8, 2023.
  2. ↑ "ADRENAL". Pronunciation in English. December 6, 2023. Retrieved December 8, 2023.
  3. ↑ "CRISIS". Pronunciation in English. November 9, 2022. Retrieved December 8, 2023.
  4. 1 2 3 4 5 6 7 8 Elshimy, Ghada; Chippa, Venu; Kaur, Jasleen; Jeong, Jordan M. (September 13, 2023). "Adrenal Crisis". StatPearls Publishing. PMID   29763143 . Retrieved December 8, 2023.
  5. 1 2 3 4 5 6 7 8 9 Puar TH, Stikkelbroeck NM, Smans LC, Zelissen PM, Hermus AR (March 2016). "Adrenal Crisis: Still a Deadly Event in the 21st Century". The American Journal of Medicine. 129 (3). Elsevier BV: 339.e1–339.e9. doi: 10.1016/j.amjmed.2015.08.021 . PMID   26363354. S2CID   205472441.
  6. 1 2 3 4 5 6 7 8 Hahner S, Spinnler C, Fassnacht M, Burger-Stritt S, Lang K, Milovanovic D, et al. (February 2015). "High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study". The Journal of Clinical Endocrinology and Metabolism. 100 (2). The Endocrine Society: 407–416. doi: 10.1210/jc.2014-3191 . PMID   25419882.
  7. 1 2 3 4 5 Rushworth RL, Torpy DJ, Falhammar H (February 2017). "Adrenal crises: perspectives and research directions". Endocrine. 55 (2). Springer Science and Business Media LLC: 336–345. doi:10.1007/s12020-016-1204-2. PMID   27995500. S2CID   7786273.
  8. 1 2 3 4 Bouillon R (December 2006). "Acute adrenal insufficiency". Endocrinology and Metabolism Clinics of North America. 35 (4). Elsevier BV: 767–75, ix. doi:10.1016/j.ecl.2006.09.004. PMID   17127145.
  9. 1 2 3 4 5 6 7 8 Rushworth RL, Torpy DJ, Falhammar H (August 2019). "Adrenal Crisis". The New England Journal of Medicine. 381 (9): 852–861. doi:10.1056/NEJMra1807486. PMID   31461595. S2CID   263427558.
  10. 1 2 Omori K, Nomura K, Shimizu S, Omori N, Takano K (December 2003). "Risk factors for adrenal crisis in patients with adrenal insufficiency". Endocrine Journal. 50 (6). Japan Endocrine Society: 745–752. doi: 10.1507/endocrj.50.745 . PMID   14709847.
  11. 1 2 3 Oelkers W (October 1996). "Adrenal insufficiency". The New England Journal of Medicine. 335 (16). Massachusetts Medical Society: 1206–1212. doi:10.1056/nejm199610173351607. PMID   8815944.
  12. 1 2 Kazlauskaite R, Evans AT, Villabona CV, Abdu TA, Ambrosi B, Atkinson AB, et al. (November 2008). "Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis". The Journal of Clinical Endocrinology and Metabolism. 93 (11). The Endocrine Society: 4245–4253. doi: 10.1210/jc.2008-0710 . PMID   18697868.
  13. 1 2 Allolio, Bruno (2015). "EXTENSIVE EXPERTISE IN ENDOCRINOLOGY: Adrenal crisis". European Journal of Endocrinology. 172 (3). Oxford University Press (OUP): R115–R124. doi: 10.1530/eje-14-0824 . ISSN   0804-4643. PMID   25288693.
  14. ↑ Zelissen PM (1994). "Addison patients in the Netherlands: medical report of the survey". The Hague: Dutch Addison Society.
  15. ↑ Allolio B, Ehses W, Steffen HM, Müller R (June 1994). "Reduced lymphocyte beta 2-adrenoceptor density and impaired diastolic left ventricular function in patients with glucocorticoid deficiency". Clinical Endocrinology. 40 (6): 769–775. doi:10.1111/j.1365-2265.1994.tb02511.x. PMID   8033368. S2CID   695195.
  16. ↑ Shanthosh Kumar S, Nagesh VK, Hunter J, Sange I (September 2021). "A Case of Severe Hyponatremia in a Patient With Primary Adrenal Insufficiency". Cureus. 13 (9). Cureus, Inc.: e17946. doi: 10.7759/cureus.17946 . PMC   8514201 . PMID   34660134.
  17. 1 2 Arlt W, Allolio B (May 2003). "Adrenal insufficiency". Lancet. 361 (9372). Elsevier BV: 1881–1893. doi:10.1016/s0140-6736(03)13492-7. PMID   12788587. S2CID   7506593.
  18. ↑ Martin-Grace, Julie; Dineen, Rosemary; Sherlock, Mark; Thompson, Christopher J (2020). "Adrenal insufficiency: Physiology, clinical presentation and diagnostic challenges". Clinica Chimica Acta. 505. Elsevier BV: 78–91. doi:10.1016/j.cca.2020.01.029. ISSN   0009-8981.
  19. ↑ Luman W, Gray RS, Pendek R, Palmer KR (April 1994). "Prednisolone metasulphobenzoate foam retention enemas suppress the hypothalamo-pituitary-adrenal axis". Alimentary Pharmacology & Therapeutics. 8 (2). Wiley: 255–258. doi:10.1111/j.1365-2036.1994.tb00284.x. PMID   8038357. S2CID   2886370.
  20. ↑ Yang H, Trbovich M, Harrow J (November 2014). "Secondary adrenal insufficiency after glucocorticosteroid administration in acute spinal cord injury: a case report". The Journal of Spinal Cord Medicine. 37 (6). Informa UK Limited: 786–790. doi: 10.1179/2045772314y.0000000223 . PMC   4231968 . PMID   24969098.
  21. ↑ Finken MJ, Mul D (September 2010). "Cushing's syndrome and adrenal insufficiency after intradermal triamcinolone acetonide for keloid scars". European Journal of Pediatrics. 169 (9). Springer Science and Business Media LLC: 1147–1149. doi: 10.1007/s00431-010-1165-z . PMID   20186428.
  22. ↑ Johnston PC, Lansang MC, Chatterjee S, Kennedy L (March 2015). "Intra-articular glucocorticoid injections and their effect on hypothalamic-pituitary-adrenal (HPA)-axis function". Endocrine. 48 (2). Springer Science and Business Media LLC: 410–416. doi:10.1007/s12020-014-0409-5. PMID   25182149. S2CID   207363039.
  23. ↑ Habib G, Jabbour A, Artul S, Hakim G (January 2014). "Intra-articular methylprednisolone acetate injection at the knee joint and the hypothalamic-pituitary-adrenal axis: a randomized controlled study". Clinical Rheumatology. 33 (1). Springer Science and Business Media LLC: 99–103. doi:10.1007/s10067-013-2374-4. PMID   23982564. S2CID   31438068.
  24. ↑ Loaiza-Bonilla A, Sullivan T, Harris RK (2010). "Lost in the mist: acute adrenal crisis following intranasal fluticasone propionate overuse". Case Reports in Medicine. 2010. Hindawi Limited: 1–4. doi: 10.1155/2010/846534 . PMC   2939498 . PMID   20862350.
  25. ↑ Woods CP, Argese N, Chapman M, Boot C, Webster R, Dabhi V, et al. (November 2015). "Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol". European Journal of Endocrinology. 173 (5). Oxford University Press (OUP): 633–642. doi: 10.1530/eje-15-0608 . PMC   4588051 . PMID   26294794.
  26. ↑ Levin C, Maibach HI (2002). "Topical corticosteroid-induced adrenocortical insufficiency: clinical implications". American Journal of Clinical Dermatology. 3 (3). Springer Science and Business Media LLC: 141–147. doi:10.2165/00128071-200203030-00001. PMID   11978135. S2CID   58051887.
  27. ↑ Hopkins RL, Leinung MC (June 2005). "Exogenous Cushing's syndrome and glucocorticoid withdrawal". Endocrinology and Metabolism Clinics of North America. 34 (2). Elsevier BV: 371–84, ix. doi:10.1016/j.ecl.2005.01.013. PMID   15850848.
  28. ↑ St Clair K, Maguire JD (May 2012). "Role of fluconazole in a case of rapid onset ritonavir and inhaled fluticasone-associated secondary adrenal insufficiency". International Journal of STD & AIDS. 23 (5): 371–372. doi:10.1258/ijsa.2009.009339. PMID   22648897. S2CID   2193364.
  29. ↑ Bolland MJ, Bagg W, Thomas MG, Lucas JA, Ticehurst R, Black PN (January 2004). "Cushing's syndrome due to interaction between inhaled corticosteroids and itraconazole". The Annals of Pharmacotherapy. 38 (1). SAGE Publications: 46–49. doi:10.1345/aph.1d222. PMID   14742792. S2CID   24050351.
  30. ↑ Broersen LH, Pereira AM, Jørgensen JO, Dekkers OM (June 2015). "Adrenal Insufficiency in Corticosteroids Use: Systematic Review and Meta-Analysis". The Journal of Clinical Endocrinology and Metabolism. 100 (6). The Endocrine Society: 2171–2180. doi: 10.1210/jc.2015-1218 . PMID   25844620.
  31. 1 2 3 Hahner S, Loeffler M, Bleicken B, Drechsler C, Milovanovic D, Fassnacht M, et al. (March 2010). "Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies". European Journal of Endocrinology. 162 (3). Oxford University Press (OUP): 597–602. doi:10.1530/eje-09-0884. PMID   19955259. S2CID   35229693.
  32. 1 2 3 White K, Arlt W (January 2010). "Adrenal crisis in treated Addison's disease: a predictable but under-managed event". European Journal of Endocrinology. 162 (1). Oxford University Press (OUP): 115–120. doi:10.1530/eje-09-0559. PMID   19776201.
  33. ↑ Graves L, Klein RM, Walling AD (August 2003). "Addisonian crisis precipitated by thyroxine therapy: a complication of type 2 autoimmune polyglandular syndrome". Southern Medical Journal. 96 (8). Southern Medical Association: 824–827. doi:10.1097/01.smj.0000056647.58668.cd. PMID   14515930. S2CID   46328960.
  34. ↑ Bornstein SR (May 2009). "Predisposing factors for adrenal insufficiency". The New England Journal of Medicine. 360 (22). Massachusetts Medical Society: 2328–2339. doi:10.1056/nejmra0804635. PMID   19474430.
  35. ↑ Yadav J, Satapathy AK, Jain V (September 2015). "Addisonian Crisis Due to Antitubercular Therapy". Indian Journal of Pediatrics. 82 (9): 860. doi: 10.1007/s12098-015-1742-2 . PMID   25772943. S2CID   2558895.
  36. ↑ Scherholz ML, Schlesinger N, Androulakis IP (2019). "Chronopharmacology of glucocorticoids". Advanced Drug Delivery Reviews. 151–152. Elsevier BV: 245–261. doi: 10.1016/j.addr.2019.02.004 . PMC   6703983 . PMID   30797955.
  37. ↑ Annane D, Bellissant E, Sebille V, Lesieur O, Mathieu B, Raphael JC, Gajdos P (December 1998). "Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve". British Journal of Clinical Pharmacology. 46 (6). Wiley: 589–597. doi: 10.1046/j.1365-2125.1998.00833.x . PMC   1873798 . PMID   9862249.
  38. ↑ Dinneen S, Alzaid A, Miles J, Rizza R (November 1993). "Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans". The Journal of Clinical Investigation. 92 (5). American Society for Clinical Investigation: 2283–2290. doi: 10.1172/jci116832 . PMC   288409 . PMID   8227343.
  39. 1 2 3 Simpson H, Tomlinson J, Wass J, Dean J, Arlt W (July 2020). "Guidance for the prevention and emergency management of adult patients with adrenal insufficiency". Clinical Medicine. 20 (4). Royal College of Physicians: 371–378. doi: 10.7861/clinmed.2019-0324 . PMC   7385786 . PMID   32675141.
  40. ↑ Aso K, Izawa M, Higuchi A, Kotoh S, Hasegawa Y (2009). "Stress doses of glucocorticoids cannot prevent progression of all adrenal crises". Clinical Pediatric Endocrinology. 18 (1). Japanese Society for Pediatric Endocrinology: 23–27. doi: 10.1297/cpe.18.23 . PMC   4004880 . PMID   24790376.
  41. ↑ Repping-Wuts HJ, Stikkelbroeck NM, Noordzij A, Kerstens M, Hermus AR (July 2013). "A glucocorticoid education group meeting: an effective strategy for improving self-management to prevent adrenal crisis". European Journal of Endocrinology. 169 (1). Oxford University Press (OUP): 17–22. doi: 10.1530/eje-12-1094 . PMID   23636446.
  42. ↑ Flemming TG, Kristensen LO (November 1999). "Quality of self-care in patients on replacement therapy with hydrocortisone". Journal of Internal Medicine. 246 (5). Wiley: 497–501. doi: 10.1046/j.1365-2796.1999.00538.x . PMID   10583719.
  43. ↑ Peacey SR, Pope RM, Naik KS, Hardern RD, Page MD, Belchetz PE (April 1993). "Corticosteroid therapy and intercurrent illness: the need for continuing patient education". Postgraduate Medical Journal. 69 (810). Oxford University Press (OUP): 282–284. doi: 10.1136/pgmj.69.810.282 . PMC   2399661 . PMID   8321791.
  44. ↑ Hahner S, Hemmelmann N, Quinkler M, Beuschlein F, Spinnler C, Allolio B (April 2015). "Timelines in the management of adrenal crisis — targets, limits and reality". Clinical Endocrinology. 82 (4): 497–502. doi:10.1111/cen.12609. PMID   25200922. S2CID   25790150.
  45. ↑ Wass JA, Arlt W (October 2012). "How to avoid precipitating an acute adrenal crisis". BMJ. 345 (oct09 3): e6333. doi:10.1136/bmj.e6333. PMID   23048013. S2CID   206896277.
  46. ↑ Dineen R, Thompson CJ, Sherlock M (2019). "Adrenal crisis: prevention and management in adult patients". Therapeutic Advances in Endocrinology and Metabolism. 10: 2042018819848218. doi: 10.1177/2042018819848218 . PMC   6566489 . PMID   31223468.
  47. 1 2 Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, et al. (February 2016). "Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline". The Journal of Clinical Endocrinology and Metabolism. 101 (2). The Endocrine Society: 364–389. doi: 10.1210/jc.2015-1710 . PMC   4880116 . PMID   26760044.
  48. ↑ Gagliardi L, Nenke MA, Thynne TR, von der Borch J, Rankin WA, Henley DE, et al. (November 2014). "Continuous subcutaneous hydrocortisone infusion therapy in Addison's disease: a randomized, placebo-controlled clinical trial". The Journal of Clinical Endocrinology and Metabolism. 99 (11). The Endocrine Society: 4149–4157. doi: 10.1210/jc.2014-2433 . PMID   25127090.
  49. 1 2 Husebye ES, Allolio B, Arlt W, Badenhoop K, Bensing S, Betterle C, et al. (February 2014). "Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency". Journal of Internal Medicine. 275 (2): 104–115. doi: 10.1111/joim.12162 . PMID   24330030.
  50. ↑ Verbalis JG, Goldsmith SR, Greenberg A, Korzelius C, Schrier RW, Sterns RH, Thompson CJ (October 2013). "Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations". The American Journal of Medicine. 126 (10 Suppl 1). Elsevier BV: S1-42. doi:10.1016/j.amjmed.2013.07.006. PMID   24074529.
  51. ↑ Bergthorsdottir, Ragnhildur; Leonsson-Zachrisson, Maria; Odén, Anders; Johannsson, Gudmundur (December 1, 2006). "Premature Mortality in Patients with Addison's Disease: A Population-Based Study". The Journal of Clinical Endocrinology & Metabolism. 91 (12). The Endocrine Society: 4849–4853. doi: 10.1210/jc.2006-0076 . ISSN   0021-972X. PMID   16968806.
  52. ↑ Sævik, Å. B.; Åkerman, A.-K.; Grønning, K.; Nermoen, I.; Valland, S. F.; Finnes, T. E.; Isaksson, M.; Dahlqvist, P.; Bergthorsdottir, R.; Ekwall, O.; Skov, J.; Nedrebø, B. G.; Hulting, A.-L.; Wahlberg, J.; Svartberg, J.; Höybye, C.; Bleskestad, I. H.; Jørgensen, A. P.; Kämpe, O.; Øksnes, M.; Bensing, S.; Husebye, E. S. (November 3, 2017). "Clues for early detection of autoimmune Addison's disease – myths and realities". Journal of Internal Medicine. 283 (2). Wiley: 190–199. doi: 10.1111/joim.12699 . ISSN   0954-6820. PMID   29098731.
  53. ↑ Smans, Lisanne C.C.J.; Van der Valk, Eline S.; Hermus, Ad R.M.M.; Zelissen, Pierre M.J. (August 27, 2015). "Incidence of adrenal crisis in patients with adrenal insufficiency". Clinical Endocrinology. 84 (1). Wiley: 17–22. doi:10.1111/cen.12865. ISSN   0300-0664. PMID   26208266. S2CID   34814447.
  54. 1 2 Rushworth, R. Louise; Chrisp, Georgina L.; Torpy, David J. (2018). "Glucocorticoid-Induced Adrenal Insufficiency: A Study of the Incidence in Hospital Patients and A Review of Peri-Operative Management". Endocrine Practice. 24 (5). Elsevier BV: 437–445. doi:10.4158/ep-2017-0117. ISSN   1530-891X. PMID   29498915.
  55. ↑ Goubar, Thomas; Torpy, David J.; McGrath, Shaun; Rushworth, R. Louise (1 December 2019). "Prehospital Management of Acute Addison Disease: Audit of Patients Attending a Referral Hospital in a Regional Area". Journal of the Endocrine Society. 3 (12): 2194–2203. doi: 10.1210/js.2019-00263 . ISSN   2472-1972. PMC   6839527 . PMID   31723718.
  56. ↑ Falhammar, Henrik; Lindh, Jonatan D.; Calissendorff, Jan; Farmand, Shermineh; Skov, Jakob; Nathanson, David; Mannheimer, Buster (2018). "Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: A population–based case–control study". Seizure. 59. Elsevier BV: 28–33. doi: 10.1016/j.seizure.2018.04.025 . ISSN   1059-1311. PMID   29730273.
  57. ↑ Regal, Milagros; Páramo, Concepción; Sierra, José M.; García-Mayor, Ricardo V. (2001). "Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain". Clinical Endocrinology. 55 (6): 735–740. doi:10.1046/j.1365-2265.2001.01406.x. ISSN   0300-0664. PMID   11895214. S2CID   41502818 . Retrieved December 11, 2023.
  58. ↑ Iwasaku, Masahiro; Shinzawa, Maki; Tanaka, Shiro; Kimachi, Kimihiko; Kawakami, Koji (2017). "Clinical characteristics of adrenal crisis in adult population with and without predisposing chronic adrenal insufficiency: a retrospective cohort study". BMC Endocrine Disorders. 17 (1): 58. doi: 10.1186/s12902-017-0208-0 . ISSN   1472-6823. PMC   5594557 . PMID   28893233.
  59. ↑ Chen, Yi-Chun; Chen, Yu-Chun; Chou, Li-Fang; Chen, Tzeng-Ji; Hwang, Shinn-Jang (2010). "Adrenal Insufficiency in the Elderly: A Nationwide Study of Hospitalizations in Taiwan". The Tohoku Journal of Experimental Medicine. 221 (4). Tohoku University Medical Press: 281–285. doi: 10.1620/tjem.221.281 . ISSN   0040-8727. PMID   20644343 . Retrieved December 11, 2023.
  60. 1 2 Rushworth, R Louise; Torpy, David J (2014). "A descriptive study of adrenal crises in adults with adrenal insufficiency: increased risk with age and in those with bacterial infections". BMC Endocrine Disorders. 14 (1): 79. doi: 10.1186/1472-6823-14-79 . ISSN   1472-6823. PMC   4200115 . PMID   25273066.
  61. ↑ Falhammar, Henrik; Thorén, Marja (2012). "Clinical outcomes in the management of congenital adrenal hyperplasia". Endocrine. 41 (3): 355–373. doi:10.1007/s12020-011-9591-x. ISSN   1355-008X. PMID   22228497. S2CID   22387824 . Retrieved December 11, 2023.
  62. ↑ Quinkler, Marcus; Ekman, Bertil; Zhang, Pinggao; Isidori, Andrea M.; Murray, Robert D.; on behalf of the EU-AIR Investigators (2018). "Mortality data from the European Adrenal Insufficiency Registry—Patient characterization and associations". Clinical Endocrinology. 89 (1): 30–35. doi: 10.1111/cen.13609 . ISSN   0300-0664. PMID   29682773.
  63. ↑ Manoharan, Madhavi; Sinha, Prabha; Sibtain, Shabnum (2020-08-17). "Adrenal disorders in pregnancy, labour and postpartum – an overview". Journal of Obstetrics and Gynaecology. 40 (6): 749–758. doi:10.1080/01443615.2019.1648395. ISSN   0144-3615. PMID   31469031. S2CID   201673660 . Retrieved December 11, 2023.
  64. ↑ Oliveira, Diana; Lages, Adriana; Paiva, Sandra; Carrilho, Francisco (April 12, 2018). "Treatment of Addison's disease during pregnancy". Endocrinology, Diabetes & Metabolism Case Reports. 2018. Bioscientifica. doi: 10.1530/edm-17-0179 . ISSN   2052-0573. PMC   5900459 . PMID   29675257.
  65. ↑ Langlois, Fabienne; Lim, Dawn S.T.; Fleseriu, Maria (2017). "Update on adrenal insufficiency: diagnosis and management in pregnancy". Current Opinion in Endocrinology, Diabetes & Obesity. 24 (3). Ovid Technologies (Wolters Kluwer Health): 184–192. doi:10.1097/med.0000000000000331. ISSN   1752-296X. PMID   28288009. S2CID   25838831 . Retrieved December 11, 2023.
  66. ↑ MacKinnon, Rene; Eubanks, Allison; Shay, Kelly; Belson, Brian (2021). "Diagnosing and managing adrenal crisis in pregnancy: A case report". Case Reports in Women's Health. 29. Elsevier BV: e00278. doi: 10.1016/j.crwh.2020.e00278 . ISSN   2214-9112. PMC   7758514 . PMID   33376678.
  67. ↑ DeVile, C. J.; Stanhope, R. (1997). "Hydrocortisone replacement therapy in children and adolescents with hypopituitarism". Clinical Endocrinology. 47 (1). Wiley: 37–41. doi:10.1046/j.1365-2265.1997.2101025.x. ISSN   0300-0664. PMID   9302370. S2CID   26602285.
  68. 1 2 Webb, Emma A.; Krone, Nils (2015). "Current and novel approaches to children and young people with congenital adrenal hyperplasia and adrenal insufficiency" (PDF). Best Practice & Research Clinical Endocrinology & Metabolism. 29 (3). Elsevier BV: 449–468. doi:10.1016/j.beem.2015.04.002. ISSN   1521-690X. PMID   26051302. S2CID   3098283.
  69. ↑ Charmandari, Evangelia; Eisenhofer, Graeme; Mehlinger, Sarah L.; Carlson, Ann; Wesley, Robert; Keil, Margaret F.; Chrousos, George P.; New, Maria I.; Merke, Deborah P. (2002). "Adrenomedullary Function May Predict Phenotype and Genotype in Classic 21-Hydroxylase Deficiency". The Journal of Clinical Endocrinology & Metabolism. 87 (7). The Endocrine Society: 3031–3037. doi: 10.1210/jcem.87.7.8664 . ISSN   0021-972X. PMID   12107196. S2CID   6642438.
  70. ↑ Parham, Walter A.; Mehdirad, Ali A.; Biermann, Kurt M.; Fredman, Carey S. (2006). "Hyperkalemia Revisited". Texas Heart Institute Journal. 33 (1). Texas Heart Institute: 40–47. PMC   1413606 . PMID   16572868.
  71. ↑ Rushworth, R. Louise; Falhammar, Henrik; Munns, Craig F.; Maguire, Ann M.; Torpy, David J. (2016). "Hospital Admission Patterns in Children with CAH: Admission Rates and Adrenal Crises Decline with Age". International Journal of Endocrinology. 2016. Hindawi Limited: 1–7. doi: 10.1155/2016/5748264 . ISSN   1687-8337. PMC   4736605 . PMID   26880914.
  72. ↑ Yang, Ming; White, Perrin C. (March 9, 2017). "Risk factors for hospitalization of children with congenital adrenal hyperplasia". Clinical Endocrinology. 86 (5). Wiley: 669–673. doi:10.1111/cen.13309. ISSN   0300-0664. PMID   28192635. S2CID   3053051.
  73. ↑ Rushworth, R. Louise; Chrisp, Georgina L.; Dean, Benjamin; Falhammar, Henrik; Torpy, David J. (2017). "Hospitalisation in Children with Adrenal Insufficiency and Hypopituitarism: Is There a Differential Burden between Boys and Girls and between Age Groups?". Hormone Research in Paediatrics. 88 (5). S. Karger AG: 339–346. doi:10.1159/000479370. ISSN   1663-2818. PMID   28898882. S2CID   8842956.
  74. ↑ Lass, Nina; Reinehr, Thomas (2015). "Low Treatment Adherence in Pubertal Children Treated with Thyroxin or Growth Hormone". Hormone Research in Paediatrics. 84 (4). S. Karger AG: 240–247. doi:10.1159/000437305. ISSN   1663-2818. PMID   26279278. S2CID   32377896.
  75. ↑ Charmandari, Evangelia; Hindmarsh, Peter C.; Johnston, Atholl; Brook, Charles G. D. (June 1, 2001). "Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency: Alterations in Cortisol Pharmacokinetics at Puberty". The Journal of Clinical Endocrinology & Metabolism. 86 (6). The Endocrine Society: 2701–2708. doi: 10.1210/jcem.86.6.7522 . ISSN   0021-972X. PMID   11397874. S2CID   22329109.

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.